Veröffentlichungen

Stürzl, R., Gerken, M., Bruns, C., Klinkhammer-Schalke, M., Pauer, A., Piso, P., 2022. [Surgical treatment of adenocarcinoma of the esophagogastric junction type II : Comparison between transhiatal extended gastrectomy and thoracoabdominal esophagectomy]. Chirurgie (Heidelb) 93, 1072–1081.

Teufel, A., Li, M., Gerken, M., Ebert, M.P., Schlitt, H.J., Evert, M., Herr, W., Klinkhammer-Schalke, M., 2022. Second cancer after adjuvant chemotherapy in patients with colon cancer. JCO 40, 86–86.

Voelkel, V., Draeger, T., van Mossel, S., Siesling, S., Koffijberg, H., 2022. The value of time-dependent risk predictions in a screening context – a comprehensive simulation analysis validated on German cancer registry data. BMC Med Res Methodol 22, 239.

Völkel, V., Schatz, S., Draeger, T., Gerken, M., Klinkhammer-Schalke, M., Fürst, A., 2022. Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in Germany. Surg Endosc 36, 1172–1180.

Stuerzl, R., Gerken, M., Klinkhammer-Schalke, M., Pauer, A., Piso, P., 2022. Comparison of esophagectomy and gastrectomy in patients with adenocarcinoma of the esophagogastric junction (AEG) type II – a retrospective cohort study on overall, recurrence free survival and recurrence rates. Oncol. Res. Treat. 45, 83–83.

Gennari, P., Tchaikovski, S., Mészáros, J., Gerken, M., Klinkhammer-Schalke, M., Toth, G., Ortmann, O., Eggemann, H., Ignatov, A., 2022. Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer. Gynecol Oncol 166, 57–60.

Filippini Velázquez, G., Schiele, S., Gerken, M., Neumaier, S., Hackl, C., Mayr, P., Klinkhammer-Schalke, M., Illerhaus, G., Schlitt, H.J., Anthuber, M., Kröncke, T., Messmann, H., Märkl, B., Schmid, C., Trepel, M., Müller, G., Claus, R., Hackanson, B., 2022. Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer. ESMO Open 7, 100470.

Geraedts, M., Bierbaum, T., Groene, O., Haerter, M., Hildebrandt, H., Hoffmann, W., Klinkhammer-Schalke, M., Koeberlein-Neu, J., Schmitt, J., 2022a. Position Paper of German Network Health Services Research Methods and Indicator Sets for the Evaluation of regional sector-linking Care Models. Gesundheitswesen 84, 484-+.

Graf, M., Gerken, M., Klinkhammer-Schalke, M., Schrodi, S., Engel, J., Pauer, A., Ortmann, O., Inwald, E.C., 2022. Comparison of clinical, histopathological, therapeutic factors and survival between 2510 male and 307634 female patients with invasive breast cancer – results from a large population-based cohort study in Germany. Oncol. Res. Treat. 45, 29–29.

Gumpp, J., Kupper, A., Gerken, M., Pauer, A., Klinkhammer-Schalke, M., Rau, B.M., 2022. Implementation and benefit of the S3 guideline in resected pancreatic cancer: results of a population-based multicenter registry study in East Bavaria. Oncol. Res. Treat. 45, 86–86.

Inwald, E. C., Gerken, M., Pauer, A., Klinkhammer-Schalke, M., Ortmann, O., 2022. Influence of the COVID-19 Pandemic on the Incidence, Stage Distribution and Therapies of Cancer. Geburtshilfe Frauenheilkd. 82, 644–644.

Inwald, Elisabeth C., Gerken, M., Pauer, A., Klinkhammer-Schalke, M., Ortmann, O., 2022. Influence of the COVID-19 pandemic on the incidence, stages and treatment of cancer. Oncol. Res. Treat. 45, 58–58.

Oswald, J., Robold, T., Gerken, M., Horn, L., Fitilidis, K., Klinkhammer-Schalke, M., Hofmann, H.-S., 2022. Comparison of lung cancer-centers and non-centers: Regional differences in the patients characteristics and therapy of bronchial carcinoma? Oncol. Res. Treat. 45, 155–155.

Rapple, S., Gerken, M., Hatzipanagiotou, M., Ugocsai, P., Klinkhammer-Schalke, M., Pauer, A., Ortmann, O., Seitz, S., 2022. Evaluation of Local Recurrence and Overall Survival in Patients with Triple-negative Breast Cancer depending on Surgical Procedure. Oncol. Res. Treat. 45, 36–36.

Reinacher-Schick, A., Piso, P., Fokas, E., Ebert, M., Zimmermann, T., Wedding, U., Lugnier, C., Kraeft, A.-L., Schoffer, O., Sommerlatte, S., Birkner, T., Foerster, S., Benz, S.R., Klinkhammer-Schalke, M., Knauf, W., Hofheinz, R.-D., Tannapfel, A., Schmitt, J., Woermann, B., Schildmann, J., 2022. S1 Guideline for prioritisation in gastrointestinal cancer care – scarcity of ressources in the pandemic context. Oncol. Res. Treat. 45, 138–139.

Roessler, M., Schmitt, J., Bobeth, C., Gerken, M., Kleihues-van Tol, K., Reissfelder, C., Rau, B.M., Distler, M., Piso, P., Günster, C., Klinkhammer-Schalke, M., Schoffer, O., Bierbaum, V., 2022. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. BMC Cancer 22, 621.

Scharl, S., Sprötge, T., Gerken, M., Scharl, A., Ignatov, A., Inwald, E.C., Ortmann, O., Kölbl, O., Klinkhammer-Schalke, M., Papathemelis, T., 2022. Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study. Arch Gynecol Obstet 305, 203–213.

Spoerl, Steffen, Gerken, M., Chamilos, C., Spoerl, Silvia, Fischer, R., Vielsmeier, V., Künzel, J., Bohr, C., Meier, J.K., Ettl, T., Reichert, T.E., Spanier, G., 2022a. Clinical significance of panendoscopy in initial staging of oral squamous cell carcinoma and detection of synchronous second malignancies of the upper aerodigestive tract – Insights from a retrospective population-based cohort study. J Craniomaxillofac Surg 50, 515–522.

Spoerl, Steffen, Gerken, M., Schimnitz, S., Taxis, J., Fischer, R., Lindner, S.R., Ettl, T., Ludwig, N., Spoerl, Silvia, Reichert, T.E., Spanier, G., 2022b. Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study. Curr Oncol 29, 9660–9670.

Spoerl, Steffen, Spoerl, Silvia, Reil, S., Gerken, M., Ludwig, N., Taxis, J., Fischer, R., Ettl, T., Reichert, T.E., Spanier, G., 2022c. Prognostic Value of Perineural Invasion on Survival and Recurrence in Oral Squamous Cell Carcinoma. Diagnostics (Basel) 12, 1062.

Acs, M., Gerken, M., Gajic, I., Mayr, M., Zustin, J., Piso, P., 2022a. Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg 407, 3057–3067.

Acs, M., Halmy, L., Isgandarova, S., Blaj, S., Gerken, M., Hormann, B., Piso, P., 2022b. Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre. Anticancer Res 42, 1019–1029.

Bierbaum, V., Roessler, M., Christoph, B., Gerken, M., Tol, K.K.-V., Droege, P., Kloess, A., Guenster, C., Klinkhammer-Schalke, M., Schoffer, O., Schmitt, J., 2022. Effectiveness of care in German cancer centres – evidence from the WiZen study. Oncol. Res. Treat. 45, 67–67.

Bobeth, C., Kleihues-van Tol, K., Rossler, M., Bierbaum, V., Gerken, M., Guenster, C., Droege, P., Ruhnke, T., Klinkhammer-Schalke, M., Schmitt, J., Schoffer, O., 2022. Effectiveness of Care in Certified Cancer Centers (WiZen) – Success of Data Linkage between SHI and Clinical Cancer Registries. Oncol. Res. Treat. 45, 58–59.

Bolm, L., Zemskov, S., Zeller, M., Baba, T., Roldan, J., Harrison, J.M., Petruch, N., Sato, H., Petrova, E., Lapshyn, H., Braun, R., Honselmann, K.C., Hummel, R., Dronov, O., Kirichenko, A.V., Klinkhammer-Schalke, M., Kleihues-van Tol, K., Zeissig, S.R., Rades, D., Keck, T., Fernandez-Del Castillo, C., Wellner, U.F., Wegner, R.E., 2022. Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT). Cancers (Basel) 14, 868.

Braun, R., Klinkhammer-Schalke, M., Zeissig, S.R., Kleihus van Tol, K., Bolm, L., Honselmann, K.C., Petrova, E., Lapshyn, H., Deichmann, S., Abdalla, T.S.A., Heckelmann, B., Bronsert, P., Zemskov, S., Hummel, R., Keck, T., Wellner, U.F., 2022. Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group. Cancers (Basel) 14, 3946.

Eichberger, J., Weber, F., Spanier, G., Gerken, M., Schreml, S., Schulz, D., Fiedler, M., Ludwig, N., Bauer, R.J., Reichert, T.E., Ettl, T., 2022. Loss of MMP-27 Predicts Mandibular Bone Invasion in Oral Squamous Cell Carcinoma. Cancers (Basel) 14, 4044.

Fante, M.A., Felsenstein, M., Mayer, S., Gerken, M., Klinkhammer-Schalke, M., Herr, W., Vogelhuber, M., Reichle, A., Heudobler, D., 2022. All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma. Front Oncol 12, 852987.

Deichmann, S., Dworschak, O., Kulemann, B., Höppner, J., Bolm, L., Klinkhammer-Schalke, M., Zeissig, S.R., Kleihus van Tol, K., Braun, R., Lapshyn, H., Keck, T., Wellner, U.F., Honselmann, K.C., 2022. [Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective]. Zentralbl Chir 147, 147–154.

Draeger, T., Voelkel, V., Schreuder, K., Veltman, J., Dassen, A., Strobbe, L., Heijmans, H.J., Koelemij, R., Groothuis-Oudshoorn, C.G.M., Siesling, S., 2022. Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis. Oncologist 27, e766–e773.